Therma Bright wins order for 100 Venowave units

Executive Summary

• Therma Bright Inc. has secured a strategic commercial order for an initial 100 Venowave units from Horizon Health, a major durable medical equipment (DME) leader.
• This order follows a successful 2025 proof-of-concept phase, during which Therma Bright optimized its delivery and support protocols for the U.S. market.
• Horizon Health currently prescribes over 3,000 compression products per month and maintains deep clinical ties with prestigious institutions, including MedStar Health and the University of Maryland.

Key Details

• Transaction: Initial order for 100 Venowave units.
• Counterparty: Horizon Health (headquartered in Baltimore, Md.).
• Counterparty Scale: Horizon Health manages a network that prescribes over 3,000 compression products per month and sells over 35,000 compression products annually.
• Strategic Context: The order validates the 2025 proof-of-concept phase and positions Therma Bright to capture share in the high-volume vascular recovery market in the Mid-Atlantic region and nationally.
• New Market Expansion: Therma Bright is actively investigating opportunities to position Venowave for cosmetic applications within wellness and aesthetic health care clinics across the U.S., specifically for lymphatic drainage and post-procedure recovery.
• Clinical Partnerships: Horizon Health has ties to MedStar Health, the University of Maryland, and over 50 specialized surgical centres.

Notable Quotes

• Rob Fia, CEO of Therma Bright: "Securing this 100-unit order from Horizon Health is a pivotal moment for our commercial scaling strategy... Their extensive reach into surgical centres and top-tier hospitals provides the perfect launch pad for Venowave to become a standard of care in mobile compression."
• James Stadler, Co-CEO of Horizon Health: "Our doctors and patients demand the most effective, mobile and patient-compliant solutions for vascular health... we are excited to partner with Therma Bright to integrate this unique technology into our national distribution network."
• Steve Ebner, Co-CEO of Horizon Health: "The continuum of care for patients following a major procedure is paramount... The Venowave enhances clinical outcomes by supporting patients where they are most at risk: at home."